191 related articles for article (PubMed ID: 6424952)
1. Effect of concanavalin A treatment on the allogeneic response of mice to challenge with P 815 mastocytoma: interleukin 2 treatment reverses concanavalin A suppression in vivo.
Ekstedt RD; Merdian DJ
Cell Immunol; 1984 May; 85(2):447-58. PubMed ID: 6424952
[TBL] [Abstract][Full Text] [Related]
2. Suppression of cell-mediated immunity to challenge with P 815 mastocytoma in concanavalin A-treated mice.
Ekstedt RD; Merdian DJ
Cell Immunol; 1983 Jan; 75(1):181-7. PubMed ID: 6297806
[TBL] [Abstract][Full Text] [Related]
3. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
Peavy DL; Pierce CW
J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
[TBL] [Abstract][Full Text] [Related]
5. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
Falk W; Männel DN; Dröge W
J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of macrophage function by 2-chloroadenosine.
Ohtani A; Kumazawa Y; Fujisawa H; Nishimura C
J Reticuloendothel Soc; 1982 Sep; 32(3):189-200. PubMed ID: 7153986
[TBL] [Abstract][Full Text] [Related]
7. A study of the mechanism of Con A-induced immunosuppression in vivo.
Smith SR; Umland S; Terminelli C; Watnick AS
Cell Immunol; 1984 Aug; 87(1):147-58. PubMed ID: 6234994
[TBL] [Abstract][Full Text] [Related]
8. [Cellular immune dysfunction in the NOD mouse: suppression of concanavalin A-induced responses in spleen cells by activated macrophages].
Kawase Y; Yokono K; Nagata M; Hatamori N; Akiyama H; Sakamoto T; Yonezawa K; Yaso S; Shii K; Baba S
Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):674-85. PubMed ID: 2583313
[TBL] [Abstract][Full Text] [Related]
9. Studies on induction and effector functions of concanavalin A-induced suppressor cells that limit TCGF production.
Gullberg M; Larsson EL
J Immunol; 1982 Feb; 128(2):746-50. PubMed ID: 6459384
[TBL] [Abstract][Full Text] [Related]
10. Lectin-induced cytotoxic activity in spleen cells from young and old mice. Age-related changes in types of effector cells, lymphokine production and response.
Saxena RK; Saxena QB; Adler WH
Immunology; 1988 Jul; 64(3):457-61. PubMed ID: 3137156
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
Waterfield JD; Nixon DF; Mair MG
Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
[TBL] [Abstract][Full Text] [Related]
12. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor efficacy of activated macrophages against murine glioma cells].
Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitro.
Warren HS; Woolnough JA; Lafferty KJ
Aust J Exp Biol Med Sci; 1978 Apr; 56(2):247-51. PubMed ID: 98140
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cytotoxic lymphocyte precursors: I. Interactions between concanavalin A and T cell growth factors.
Skinner M; Marbrook J
Cell Immunol; 1984 May; 85(2):519-30. PubMed ID: 6143623
[TBL] [Abstract][Full Text] [Related]
16. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
Guerne PA; Piguet PF; Vassalli P
J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
[TBL] [Abstract][Full Text] [Related]
17. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W
Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728
[TBL] [Abstract][Full Text] [Related]
18. Generation of alloreactive cytotoxic T lymphocytes: production of T cell and macrophage helper factors in addition to IL 1 and IL 2 by peritoneal cells from mice immunized to Listeria monocytogenes.
Finke JH; Sharma SD; Scott JW
J Immunol; 1981 Dec; 127(6):2354-61. PubMed ID: 6795272
[TBL] [Abstract][Full Text] [Related]
19. Mastocytoma-medicated suppression of mixed lymphocyte culture and mitogen responsiveness.
DeLustro F; Argyris BF
Cell Immunol; 1976 Jan; 21(1):177-84. PubMed ID: 129285
[No Abstract] [Full Text] [Related]
20. Immunosuppressive effect of concanavalin-A. II. In vivo suppression of cytotoxic lymphocytes generation in alloimmunized mice.
Wasik M; Skopińska E
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):331-3. PubMed ID: 749783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
